National Health Investors Inc. Earnings

National Health Investors Inc.’s revenue jumped 7.55% since last year same period to $91.39Mn in the Q2 2025. On a quarterly growth basis, National Health Investors Inc. has generated 2.34% jump in its revenue since last 3-months.

National Health Investors Inc.’s net profit jumped 4.91% since last year same period to $36.99Mn in the Q2 2025. On a quarterly growth basis, National Health Investors Inc. has generated 8.26% jump in its net profits since last 3-months.

National Health Investors Inc.’s net profit margin fell -2.46% since last year same period to 40.47% in the Q2 2025. On a quarterly growth basis, National Health Investors Inc. has generated 5.78% jump in its net profit margins since last 3-months.

National Health Investors Inc.’s price-to-earnings ratio after this Q2 2025 earnings stands at 24.76.

National Health Investors Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.79 - a 5.06% jump from last quarter’s estimates.

National Health Investors Inc.’s earning per share (EPS) estimates for the current year stand at 0.79.

National Health Investors Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the National Health Investors Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

National Health Investors Inc. declared 0.92 dividend per share during the earnings announcement for Q3 2025.